Search

Your search keyword '"Negative HBV DNA"' showing total 3 results
Start Over Descriptor "Negative HBV DNA"
3 results on '"Negative HBV DNA"'

1. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis

Author

Mingxing Xu, Zheng Zhou, Ruiyun Xu, Huiling Zhang, Nan Lin, and Yuesi Zhong

Subjects
Antiviral therapy, Negative HBV DNA, Hepatocellular carcinoma, Survival, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background The effect of antiviral therapy (AVT) on clinical outcomes in patients with hepatocellular carcinoma (HCC) who are seronegative for hepatitis B virus (HBV), defined as HBV DNA

Published
2019
Full Text
View/download PDF

3. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis

Author

Ruiyun Xu, Huiling Zhang, Yuesi Zhong, Nan Lin, Zheng Zhou, and Mingxing Xu

Subjects
Male, HBsAg, Negative HBV DNA, Survival, Hepatocellular carcinoma, medicine.medical_treatment, Antiviral therapy, medicine.disease_cause, Gastroenterology, 0302 clinical medicine, Risk Factors, Surgical oncology, Postoperative Period, Liver Neoplasms, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Rate, Liver, Oncology, 030220 oncology & carcinogenesis, Cohort, Female, 030211 gastroenterology & hepatology, Hepatitis B virus, medicine.medical_specialty, Carcinoma, Hepatocellular, lcsh:Surgery, Antiviral Agents, lcsh:RC254-282, Disease-Free Survival, 03 medical and health sciences, Antigen, Internal medicine, medicine, Hepatectomy, Humans, Propensity Score, Retrospective Studies, business.industry, Research, lcsh:RD1-811, medicine.disease, digestive system diseases, DNA, Viral, Propensity score matching, Virus Activation, Surgery, business
Abstract

Background The effect of antiviral therapy (AVT) on clinical outcomes in patients with hepatocellular carcinoma (HCC) who are seronegative for hepatitis B virus (HBV), defined as HBV DNA

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results